Trial status
RECRUITMENT
The trial is currently ongoing. The protocol was approved by the ethical committee board (CCER 2019–02,469) in April 2020 and by ClinicalTrials.gov (Identifier: NCT04479397) in July 2020. The recruitment started in January 2022 and is planned to be completed in January 2023.